| Literature DB >> 32104923 |
Yexian Yuan1, Pingwen Xu2, Qingyan Jiang1, Gang Shu1, Xingcai Cai1, Tao Wang1, Wentong Peng1, Jiajie Sun1, Canjun Zhu1, Cha Zhang1, Dong Yue1, Zhihui He1, Jinping Yang1, Yuxian Zeng1, Man Du1, Fenglin Zhang1, Lucas Ibrahimi2, Sarah Schaul2, Yuwei Jiang3, Jiqiu Wang4, Jia Sun5, Qiaoping Wang6, Liming Liu7, Songbo Wang1, Lina Wang1, Xiaotong Zhu1, Ping Gao1, Qianyun Xi1, Cong Yin1, Fan Li1, Guli Xu1, Yongliang Zhang1.
Abstract
Beneficial effects of resistance exercise on metabolic health and particularly muscle hypertrophy and fat loss are well established, but the underlying chemical and physiological mechanisms are not fully understood. Here, we identified a myometabolite-mediated metabolic pathway that is essential for the beneficial metabolic effects of resistance exercise in mice. We showed that substantial accumulation of the tricarboxylic acid cycle intermediate α-ketoglutaric acid (AKG) is a metabolic signature of resistance exercise performance. Interestingly, human plasma AKG level is also negatively correlated with BMI. Pharmacological elevation of circulating AKG induces muscle hypertrophy, brown adipose tissue (BAT) thermogenesis, and white adipose tissue (WAT) lipolysis in vivo. We further found that AKG stimulates the adrenal release of adrenaline through 2-oxoglutarate receptor 1 (OXGR1) expressed in adrenal glands. Finally, by using both loss-of-function and gain-of-function mouse models, we showed that OXGR1 is essential for AKG-mediated exercise-induced beneficial metabolic effects. These findings reveal an unappreciated mechanism for the salutary effects of resistance exercise, using AKG as a systemically derived molecule for adrenal stimulation of muscle hypertrophy and fat loss.Entities:
Keywords: zzm321990AKGzzm321990; OXGR1; lipolysis; obesity; thermogenesis
Mesh:
Substances:
Year: 2020 PMID: 32104923 PMCID: PMC7110140 DOI: 10.15252/embj.2019103304
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598